Mystical experience in the context of "Unio mystica"

Mysticism encompasses religious traditions of human transformation aided by various practices and religious experiences. Popularly, mysticism is used synonymously with mystical experience, a neologism which refers to an ecstatic unitive experience of becoming one with God, the Absolute, or all that exists.

Scholarly research since the 1970s had questioned this understanding, noting that what appears to be mysticism may also refer to the attainment of insight into ultimate or hidden truths, as in Buddhist awakening and Hindu prajna, in nondualism, and in the realisation of emptiness and ego-lessness, and also to altered states of consciousness such as samadhi.

Higher consciousness (also called expanded consciousness) is a term that has been used in various ways to label particular states of consciousness or personal development. It may be used to describe a state of liberation from the limitations of self-concept or ego, as well as a state of mystical experience in which the perceived separation between the isolated self and the world or God is transcended. It may also refer to a state of increased alertness or awakening to a new perspective. While the concept has ancient roots, practices, and techniques, it has been significantly developed as a central notion in contemporary popular spirituality, including the New Age movement.

A psychedelic experience (known colloquially as a trip) is a temporary altered state of consciousness induced by the consumption of a psychedelic substance (most commonly LSD, mescaline, psilocybin mushrooms, or DMT). For example, an acid trip is a psychedelic experience brought on by the use of LSD, while a mushroom trip is a psychedelic experience brought on by the use of psilocybin. Psychedelic experiences feature alterations in normal perception such as visual distortions and a subjective loss of self-identity, sometimes interpreted as mystical experiences. Psychedelic experiences lack predictability, as they can range from being highly pleasurable (known as a good trip) to frightening (known as a bad trip). The outcome of a psychedelic experience is heavily influenced by the person's mood, personality, expectations, and environment (also known as set and setting).

Researchers have interpreted psychedelic experiences in light of a range of scientific theories, including model psychosis theory, filtration theory, psychoanalytic theory, entropic brain theory, integrated information theory, and predictive processing. Psychedelic experiences are also induced and interpreted in religious and spiritual contexts.

Psilocin, also known as 4-hydroxy-N,N-dimethyltryptamine (4-HO-DMT), is a psychedelic drug and fungal alkaloid of the tryptamine and 4-hydroxytryptamine families. Along with its phosphate ester psilocybin, it is found in most species of psilocybin-containing mushrooms, such as Psilocybe cubensis and Psilocybe mexicana, and is the compound responsible for their hallucinogenic effects, although concentrations of psilocin are variably lower than those of psilocybin. The drug is taken orally and its effects include perceptual changes and visual effects, emotional changes, ego dissolution, time dilation, and mystical experiences, among others. Psilocybin, as well as synthetic acyl esters such as 4-AcO-DMT (psilacetin; O-acetylpsilocin) and 4-PrO-DMT (O-propionylpsilocin), are prodrugs of psilocin and have similar properties and effects.

Psilocin acts as a non-selective serotonin receptor agonist, including of the serotonin 5-HT_2A receptor among others. The drug produces its hallucinogenic effects specifically via activation of the serotonin 5-HT_2A receptor. However, other serotonin receptors, such as the serotonin 5-HT_1A and 5-HT_2C receptors, may also contribute to its effects. Notable analogues of psilocin include dimethyltryptamine (DMT), its positional isomer bufotenin (5-HO-DMT), its higher homologue 4-HO-MET (metocin), and others.